#USA #San Diego #Stem Cell Therapy #Gallant #Dr. Windsor

Gallant Takes a Major Step Forward in Veterinary Medicine

Gallant, a trailblazer in animal health biotechnology, has recently appointed Dr. Rebecca Windsor as the Director of Veterinary Affairs. With a commitment to transforming the way we address pet health, Gallant is advancing its off-the-shelf stem cell therapy specifically designed for cats suffering from refractory Feline Chronic Gingivostomatitis (FCGS). This strategic appointment, announced on May 13, 2025, comes at a pivotal time as the company seeks FDA approval for its innovative therapy.

About Dr. Rebecca Windsor

Dr. Windsor brings nearly 20 years of clinical and research expertise to Gallant. A board-certified veterinary neurologist, she graduated summa cum laude from the University of Southern California, later earning her veterinary degree from the University of California, Davis. Her extensive training includes a small animal medicine and surgery internship followed by a neurology and neurosurgery residency at UC Davis, which culminated in her board certification in 2009. Her career has seen her lead specialty hospitals across the United States, with her most recent role being Chief of the Neurology Department at Wheat Ridge Animal Hospital in Colorado.

Passionate about the power of regenerative medicine, Dr. Windsor has conducted significant stem cell research, particularly studying its effects in Pugs with a severe autoimmune brain disease. This hands-on experience has convinced her of the profound impact stem cells can have in veterinary practice. Recognized as a